Major Salivary Gland Carcinoma
2 clinical trials · Condition
◉ Watch Major Salivary Gland Carcinoma
| Record | Firm | Date |
|---|---|---|
| Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer (NCT03146650) | Northwestern University | 2017-05-19 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
Track Major Salivary Gland Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.